X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (466) 466
humans (407) 407
male (344) 344
index medicus (259) 259
adrenergic beta-agonists - pharmacology (234) 234
rats (228) 228
female (199) 199
adrenergic beta-agonists - toxicity (178) 178
pharmacology & pharmacy (163) 163
adrenergic beta-agonists - therapeutic use (158) 158
asthma (128) 128
asthma - drug therapy (128) 128
adrenergic beta-agonists - administration & dosage (126) 126
mice (105) 105
isoproterenol - toxicity (104) 104
isoproterenol - pharmacology (100) 100
adult (96) 96
dose-response relationship, drug (92) 92
toxicology (86) 86
rats, wistar (81) 81
respiratory system (81) 81
administration, inhalation (79) 79
cardiac & cardiovascular systems (79) 79
isoproterenol (76) 76
rats, sprague-dawley (72) 72
adrenergic beta-agonists - adverse effects (71) 71
drug therapy (68) 68
heart - drug effects (66) 66
bronchodilator agents - therapeutic use (61) 61
child (58) 58
middle aged (58) 58
heart (55) 55
heart rate - drug effects (55) 55
drug therapy, combination (53) 53
bronchodilator agents - administration & dosage (52) 52
care and treatment (52) 52
research (52) 52
salbutamol (51) 51
time factors (50) 50
adrenergic beta-antagonists - pharmacology (49) 49
myocardium - pathology (45) 45
adrenergic beta agonists (44) 44
myocardium - metabolism (44) 44
treatment outcome (44) 44
disease models, animal (43) 43
physiological aspects (43) 43
pregnancy (43) 43
aged (42) 42
in vitro techniques (42) 42
toxicity (42) 42
albuterol (41) 41
blood pressure - drug effects (41) 41
clenbuterol (41) 41
salmeterol (41) 41
receptors, adrenergic, beta - metabolism (40) 40
adolescent (39) 39
adrenal cortex hormones - therapeutic use (39) 39
health aspects (39) 39
oxidative stress (39) 39
albuterol - administration & dosage (38) 38
drug interactions (38) 38
heart failure (38) 38
mortality (37) 37
physiology (37) 37
activation (35) 35
albuterol - analogs & derivatives (35) 35
cells, cultured (35) 35
dosage and administration (35) 35
heart-failure (35) 35
lung diseases, obstructive (35) 35
medicine & public health (35) 35
myocardial contraction - drug effects (35) 35
pulmonary disease, chronic obstructive - drug therapy (35) 35
receptors, adrenergic, beta - drug effects (35) 35
salmeterol xinafoate (34) 34
corticosteroids (33) 33
dogs (33) 33
myocytes, cardiac - drug effects (33) 33
acute disease (32) 32
anti-asthmatic agents - therapeutic use (32) 32
cell biology (32) 32
expression (32) 32
albuterol - therapeutic use (31) 31
cells (31) 31
double-blind method (31) 31
immunology (31) 31
medicine, general & internal (31) 31
analysis (30) 30
electrocardiography (30) 30
internal medicine (30) 30
pharmacology/toxicology (30) 30
rabbits (30) 30
children (29) 29
guinea pigs (29) 29
bronchodilator agents - adverse effects (28) 28
cardiology (28) 28
hemodynamics - drug effects (28) 28
pediatrics (28) 28
rodents (28) 28
beta-adrenergic receptor (27) 27
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (822) 822
French (6) 6
Japanese (6) 6
German (3) 3
Chinese (2) 2
Dutch (2) 2
Polish (2) 2
Russian (2) 2
Hebrew (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 05/2011, Volume 57, Issue 21, pp. 2127 - 2138
Journal Article
Biomedicine & Pharmacotherapy, ISSN 0753-3322, 07/2019, Volume 115, p. 108881
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2015, Volume 10, Issue 11, p. e0142212
...) to dilate obstructed airways. Such drugs include long acting beta agonists (LABAs) that are paradoxically linked to excess asthma-related mortality... 
SH2 DOMAIN | MURINE MODEL | MILD ASTHMA | SIGNALING PATHWAYS | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | EXPERIMENTAL ASTHMA | LUNG-DISEASE | MICE | TRANSCRIPTION FACTOR | BETA-ADRENERGIC RECEPTOR | Anti-Asthmatic Agents - adverse effects | Asthma - metabolism | Humans | Arrestins - genetics | STAT6 Transcription Factor - agonists | STAT6 Transcription Factor - genetics | Aspergillosis, Allergic Bronchopulmonary - drug therapy | Salmeterol Xinafoate - adverse effects | Adrenergic beta-2 Receptor Agonists - adverse effects | Bronchoconstriction - drug effects | Female | Aspergillosis, Allergic Bronchopulmonary - metabolism | Lung - metabolism | STAT6 Transcription Factor - antagonists & inhibitors | Disease Models, Animal | Receptors, Adrenergic, beta-2 - deficiency | Carbazoles - adverse effects | Gene Expression | Lung - pathology | Peptidomimetics - pharmacology | Aspergillus niger - physiology | Receptors, Adrenergic, beta-2 - genetics | Formoterol Fumarate - adverse effects | Aspergillosis, Allergic Bronchopulmonary - genetics | STAT6 Transcription Factor - metabolism | Aspergillosis, Allergic Bronchopulmonary - pathology | Asthma - drug therapy | Propanolamines - adverse effects | Asthma - chemically induced | Asthma - genetics | Mice, Knockout | Animals | beta-Arrestins | Lung - drug effects | Albuterol - therapeutic use | Mice | Arrestins - deficiency | Complications and side effects | Lung diseases, Obstructive | Care and treatment | Niger | Mortality | Influence | Research | Risk factors | Agonists (Biochemistry) | Drugs | Transcription factors | Salmeterol | Biochemistry | Kinases | Signal transduction | Airway management | Immunology | Illnesses | Respiratory tract diseases | Formoterol | Cytokines | Pharmacology | Inflammation | FDA approval | Gene expression | Disease control | Asthma | Stat6 protein | Ligands | Adrenergic receptors | Aberration | Adapter proteins | Binding sites
Journal Article
Journal Article
Journal Article
Toxicology, ISSN 0300-483X, 2009, Volume 266, Issue 1, pp. 48 - 54
Abstract Since cardiac and skeletal myotoxicity affect the development of drug candidates, it is important to detect their toxicity at an early stage of drug development... 
Emergency | Rats | Combinatorial safety biomarkers | Cardiotoxicity | Skeletal myotoxicity | DIAGNOSIS | TOXICITY | MEMANTINE | HEART | IN-VIVO | PHARMACOLOGY & PHARMACY | MOLECULAR-CLONING | TOXICOLOGY | EXPRESSION | TROPONIN | Isoproterenol - toxicity | Cholinesterase Inhibitors - toxicity | Isoproterenol - administration & dosage | Male | Muscle, Skeletal - metabolism | Troponin I - blood | Dose-Response Relationship, Drug | Troponin T - blood | Muscle, Skeletal - drug effects | Myocardium - metabolism | Adrenergic beta-Agonists - administration & dosage | Fatty Acid-Binding Proteins - blood | Carbofuran - toxicity | Toxicity Tests - methods | Adrenergic beta-Agonists - toxicity | Reproducibility of Results | Creatine Kinase - blood | Injections, Intraperitoneal | Myocardium - pathology | Biomarkers - blood | Rats, Sprague-Dawley | Animals | Aspartate Aminotransferases - blood | Carbofuran - administration & dosage | Cholinesterase Inhibitors - administration & dosage | Fatty Acid Binding Protein 3 | L-Lactate Dehydrogenase - blood | Heart - drug effects | ROC Curve | Myosin Light Chains - blood | Kinetics | Muscle, Skeletal - pathology | Creatine kinase | Myosin | Lactate dehydrogenase | Aspartate | Biological markers | Creatine | Fatty acids | Cholinesterase inhibitors | Protein binding | Proteins | Drugs | Inhibitors | Muscles | Kinases | Lesions | Blood | Index Medicus
Journal Article
Journal Article
Journal of Emergency Medicine, ISSN 0736-4679, 2016, Volume 51, Issue 3, pp. 259 - 261
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 07/2017, Volume 12, pp. 4709 - 4719
Journal Article